These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 9303508

  • 21. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
    Blatt LM, Tong MJ, McHutchison JG, Russell J, Schmid P, Conrad A.
    J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of consensus interferon in the treatment of chronic hepatitis C.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1418-23. PubMed ID: 11197053
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial.
    Zheng Y, Zhao L, Wu T, Guo S, Chen Y, Zhou T.
    Virol J; 2009 Jul 09; 6():99. PubMed ID: 19586556
    [Abstract] [Full Text] [Related]

  • 24. Randomized controlled trial of recombinant interferon-alpha 2b in the treatment of Chinese patients with chronic hepatitis C.
    Hwang SJ, Chan CY, Lu RH, Wu JC, Lee SD.
    J Interferon Cytokine Res; 1995 Jul 09; 15(7):611-6. PubMed ID: 7553231
    [Abstract] [Full Text] [Related]

  • 25. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.
    Lee WM, Reddy KR, Tong MJ, Black M, van Leeuwen DJ, Hollinger FB, Mullen KD, Pimstone N, Albert D, Gardner S.
    Hepatology; 1998 Nov 09; 28(5):1411-5. PubMed ID: 9794929
    [Abstract] [Full Text] [Related]

  • 26. Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.
    Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ.
    Hepatobiliary Pancreat Dis Int; 2005 May 09; 4(2):213-9. PubMed ID: 15908318
    [Abstract] [Full Text] [Related]

  • 27. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
    Zeuzem S, Lee JH, Franke A, Rüster B, Prümmer O, Herrmann G, Roth WK.
    Hepatology; 1998 Apr 09; 27(4):1149-56. PubMed ID: 9537457
    [Abstract] [Full Text] [Related]

  • 28. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
    Ferenci P, Stauber R, Propst A, Fiedler R, Müller C, Gschwantler M, Schütze K, Datz C, Judmaier G, Vogel W, Krejs GJ, Gangl A.
    Dig Dis Sci; 1996 Dec 09; 41(12 Suppl):103S-108S. PubMed ID: 9011466
    [Abstract] [Full Text] [Related]

  • 29. An open-label trial of consensus interferon 15 µg in the treatment of Chinese patients with chronic hepatitis C.
    Hwang S, Lee S, Chu C, Lu R, Chang F.
    Hepatol Res; 2001 Mar 26; 19(3):284-293. PubMed ID: 11251311
    [Abstract] [Full Text] [Related]

  • 30. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
    Erickson AK, Seiwert S, Gale M.
    Antivir Ther; 2008 Mar 26; 13(7):851-62. PubMed ID: 19043919
    [Abstract] [Full Text] [Related]

  • 31. A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C.
    Rumi M, Del Ninno E, Parravicini ML, Romeo R, Soffredini R, Donato MF, Wilber J, Russo A, Colombo M.
    Hepatology; 1996 Dec 26; 24(6):1366-70. PubMed ID: 8938163
    [Abstract] [Full Text] [Related]

  • 32. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.
    Med Sci Monit; 2000 Dec 26; 6(5):964-70. PubMed ID: 11208439
    [Abstract] [Full Text] [Related]

  • 33. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
    Cornberg M, Hadem J, Herrmann E, Schuppert F, Schmidt HH, Reiser M, Marschal O, Steffen M, Manns MP, Wedemeyer H.
    J Hepatol; 2006 Feb 26; 44(2):291-301. PubMed ID: 16360972
    [Abstract] [Full Text] [Related]

  • 34. Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.
    Shiffman ML, Hofmann CM, Thompson EB, Ferreira-Gonzalez A, Contos MJ, Koshy A, Luketic VA, Sanyal AJ, Mills AS, Garrett CT.
    Hepatology; 1997 Sep 26; 26(3):780-5. PubMed ID: 9303513
    [Abstract] [Full Text] [Related]

  • 35. Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study.
    Sangiovanni A, Morales R, Spinzi G, Rumi M, Casiraghi A, Ceriani R, Colombo E, Fossati M, Prada A, Tavani E, Minoli G.
    Hepatology; 1998 Mar 26; 27(3):853-6. PubMed ID: 9500717
    [Abstract] [Full Text] [Related]

  • 36. Re-treatment of chronic hepatitis C with consensus interferon .
    Heathcote EJ, Keeffe EB, Lee SS, Feinman SV, Tong MJ, Reddy KR, Albert DG, Witt K, Blatt LM.
    Hepatology; 1998 Apr 26; 27(4):1136-43. PubMed ID: 9537455
    [Abstract] [Full Text] [Related]

  • 37. The early HCV RNA dynamics in patients with acute hepatitis C treated with pegylated interferon-alpha2b.
    De Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Cariti G, Veronese L, Raiteri R, Calleri G, Di Perri G.
    Antivir Ther; 2006 Apr 26; 11(2):165-71. PubMed ID: 16640097
    [Abstract] [Full Text] [Related]

  • 38. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J.
    N Engl J Med; 1998 Nov 19; 339(21):1493-9. PubMed ID: 9819447
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G.
    Scand J Infect Dis; 1995 Nov 19; 27(5):319-24. PubMed ID: 8588128
    [Abstract] [Full Text] [Related]

  • 40. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
    Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G.
    N Engl J Med; 1994 Mar 17; 330(11):751-6. PubMed ID: 8107741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.